239 related articles for article (PubMed ID: 25431893)
21. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
22. Interindividual Variability in Drug Metabolizing Enzymes.
Volpe DA
Curr Drug Metab; 2019; 20(13):1041-1043. PubMed ID: 30117390
[No Abstract] [Full Text] [Related]
23. Multiplicity of liver drug metabolizing enzymes.
Lu AY
Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
[No Abstract] [Full Text] [Related]
24. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
25. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
Urquhart BL; Tirona RG; Kim RB
J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
[TBL] [Abstract][Full Text] [Related]
26. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
27. Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: analyses of mutations on NAT2 and C gamma P2E1 genes in a mixed Hispanic population.
Martínez C; Agúndez JA; Olivera M; Llerena A; Ramirez R; Hernández M; Benítez J
Clin Pharmacol Ther; 1998 Jun; 63(6):623-8. PubMed ID: 9663176
[TBL] [Abstract][Full Text] [Related]
28. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues.
Friedberg T
Skin Pharmacol Appl Skin Physiol; 1998; 11(2):61-9. PubMed ID: 9603656
[TBL] [Abstract][Full Text] [Related]
29. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
Drug Metab Pers Ther; 2016 Jun; 31(2):61-81. PubMed ID: 26812836
[TBL] [Abstract][Full Text] [Related]
30. Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Li J; Zhang L; Zhou H; Stoneking M; Tang K
Hum Mol Genet; 2011 Feb; 20(3):528-40. PubMed ID: 21081654
[TBL] [Abstract][Full Text] [Related]
31. Genetic basis of drug-induced liver injury: present and future.
Urban TJ; Daly AK; Aithal GP
Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD; Wang D; Sadee W
Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
[TBL] [Abstract][Full Text] [Related]
33. Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.
Krueger SK; Siddens LK; Martin SR; Yu Z; Pereira CB; Cabacungan ET; Hines RN; Ardlie KG; Raucy JL; Williams DE
Drug Metab Dispos; 2004 Dec; 32(12):1337-40. PubMed ID: 15355885
[TBL] [Abstract][Full Text] [Related]
34. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
[TBL] [Abstract][Full Text] [Related]
35. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
37. Comparative gene expression of intestinal metabolizing enzymes.
Shin HC; Kim HR; Cho HJ; Yi H; Cho SM; Lee DG; Abd El-Aty AM; Kim JS; Sun D; Amidon GL
Biopharm Drug Dispos; 2009 Nov; 30(8):411-21. PubMed ID: 19746353
[TBL] [Abstract][Full Text] [Related]
38. Genotyping for drug-metabolizing enzymes--does the promise meet the reality?
Gardiner SJ; Begg EJ
Pharmacogenomics; 2004 Dec; 5(8):1033-6. PubMed ID: 15584874
[No Abstract] [Full Text] [Related]
39. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
Ingelman-Sundberg M
Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
[TBL] [Abstract][Full Text] [Related]
40. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
